VALERIE CHROSNIAK: Open Payments
NPI 1982666590 · ALEXANDRIA, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,068 in 47 payments from 13 companies in 2025. Trend: 2023 $1,212 · 2024 $1,568 · 2025 $1,068
Food & beverage: $1,068
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 9 | $206 |
| ABBVIE INC. | 10 | $178 |
| Medtronic, Inc. | 2 | $127 |
| AstraZeneca Pharmaceuticals LP | 5 | $108 |
| Amgen Inc. | 4 | $94 |
| Novo Nordisk Inc | 4 | $91 |
| Exact Sciences Corporation | 3 | $79 |
| Astellas Pharma US Inc | 2 | $52 |
| Lundbeck LLC | 2 | $36 |
| Lilly USA, LLC | 2 | $35 |
Products named: ELIQUIS, INCEPTIV, UBRELVY, REPATHA, Cologuard Collection Kit, Veozah, PREVNAR 20, QULIPTA.
Industry payments across VA — which companies pay providers there.
